Skip to main content

Together we are beating cancer

Donate now

Cancer News

Analysis

Showing 12 out of 2532 results
This entry is part 2 of 2 in the series Minding the gap
%postcontent%
Big data

We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients? We are awash with data – but how do cancer researchers make the most of it at the scale and pace needed whilst also keeping the trust of patients?

by Cancer Research UK | Analysis | 24 February 2026

24 February 2026

This entry is part 2 of 6 in the series Data science
%postcontent%
A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

Careers

Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it... Good leadership is vital for successful science – so how, exactly, do you get good at it? Ally Walters talks us through it...

by Cancer Research UK | Analysis | 11 February 2026

11 February 2026

This entry is part 8 of 10 in the series Research Careers
%postcontent%
A picture of Westminster across the Thames on a sunny day

The UK Government has launched a National Cancer Plan for England. We break down what's in the plan and what it means for people affected by cancer. The UK Government has launched a National Cancer Plan for England. We break down what's in the plan and what it means for people affected by cancer.

by Matt Sample | Analysis | 4 February 2026

4 February 2026

Minding the gap

Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up… Tim Bodicoat ponders the thawing of the biotech winter and asks if the market can ever tell you if it’s the right time to launch a start-up…

by Tim Bodicoat | Analysis | 3 February 2026

3 February 2026

This entry is part 1 of 2 in the series Minding the gap
%postcontent%
Up and running - how to speed up clinical trials

The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could... The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could...

by Phil Prime | Analysis | 15 December 2025

15 December 2025

The Cancer Research UK team outside the Senedd.

A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion. A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion.

by Cancer Research UK | Analysis | 10 December 2025

10 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

A close up shot of a person putting the bowel cancer test sample in the sample holder to send off by mail for testing.
  • Health & Medicine
  • Policy & Insight

How are cancer screening programmes decided in the UK?

The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided? The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided?

by Cancer Research UK | Analysis | 21 November 2025

21 November 2025